Surgery Partners Inc banner

Surgery Partners Inc
NASDAQ:SGRY

Watchlist Manager
Surgery Partners Inc Logo
Surgery Partners Inc
NASDAQ:SGRY
Watchlist
Price: 12.24 USD 1.58%
Market Cap: $1.6B

Surgery Partners Inc
Note Receivable

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Surgery Partners Inc
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Surgery Partners Inc
NASDAQ:SGRY
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Universal Health Services Inc
NYSE:UHS
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Encompass Health Corp
NYSE:EHC
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tenet Healthcare Corp
NYSE:THC
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
HCA Healthcare Inc
NYSE:HCA
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ensign Group Inc
NASDAQ:ENSG
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Surgery Partners Inc
Glance View

Surgery Partners Inc., a prominent player in the healthcare industry, orchestrates a robust network of surgical facilities across the United States. The company's business model is centered around operating and acquiring a variety of healthcare services, primarily focusing on short-stay surgeries through its ambulatory surgery centers, surgical hospitals, and ancillary services. Founded in 2004, Surgery Partners has grown its footprint by honing in on cost-effective, high-quality outpatient surgery, offering a compelling alternative to traditional hospital settings. This approach not only reduces healthcare costs for patients and insurers but also provides an efficient model for physicians looking to practice in specialized surgical environments. Revenue generation for Surgery Partners is multifaceted, deriving primarily from patient service fees and strategic partnerships with healthcare providers and insurers. By maintaining a diversified portfolio that includes musculoskeletal surgeries, cardiac procedures, and other specialist operations, the company captures a broad spectrum of medical needs. Additionally, it benefits from ancillary services such as anesthesia and pathology, which are critical components of the surgical process. This integrated service offering allows Surgery Partners to maximize revenue streams while maintaining a strong presence in the outpatient surgery market. The company’s collaborative approach, working closely with physicians and leveraging strategic acquisitions, fortifies its position as a leader in the evolution toward more efficient, patient-centric healthcare delivery.

SGRY Intrinsic Value
32.83 USD
Undervaluation 63%
Intrinsic Value
Price

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett